Human Micobiome Market
Human Micobiome Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Human Micobiome Market Size and Growth
The Human Microbiome market is experiencing significant growth due to rising awareness of microbial health's impact on diseases. Currently valued at approximately $500 million, it is projected to reach $1.5 billion by 2028. Key drivers include advancements in probiotic research and increased focus on personalized medicine and preventive healthcare solutions.
Companies Covered
(Covid 19 Impact Covered)
◍ Seres Therapeutics
◍ Second Genome
◍ Rebiotix
◍ ActoGeniX
◍ Enterome BioScience
◍ AvidBiotics
◍ 4D Pharma Research Ltd
◍ Enterologics
◍ Metabogen
◍ Metabiomics
◍ Ritter Pharmaceuticals
◍ Osel
◍ Symberix
◍ Miomics
◍ Symbiotix Biotherapies
◍ MicroBiome Therapeutics LLC.
The Human Microbiome Market features companies like Seres Therapeutics and Rebiotix, focusing on therapeutic products. They develop microbiome-based treatments for gastrointestinal diseases, enhancing market growth. AvidBiotics and Enterome improve personalized medicine approaches. Sales revenues include Seres Therapeutics at approximately $33 million and Rebiotix around $10 million, driving industry advancement.
Request Sample Report
Market Segmentation
By Application
Treatment
Diagnosis
Request Sample Report
By
Product
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
Request Sample Report
